✦ LIBER ✦

Randomized multicenter clinical trial with imipenem/cilastatin versus cefotaxime/gentamicin in the treatment of patients with non-life-threatening infections

Publisher: Springer
Year: 1992
Tongue: English
Weight: 999 KB
Volume: 11
Category: Article
ISSN: 0934-9723
DOI: 10.1007/bf01989971

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The efficacy and safety of abatacept in

The efficacy and safety of abatacept in patients with non–life-threatening manifestations of systemic lupus erythematosus: Results of a twelve-month, multicenter, exploratory, phase IIb, randomized, double-blind, placebo-controlled trial

✍ J. T. Merrill; R. Burgos-Vargas; R. Westhovens; A. Chalmers; D. D'Cruz; D. J. Wa 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 222 KB 👁 3 views

The PREMIER study: A multicenter, random

The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment

✍ Ferdinand C. Breedveld; Michael H. Weisman; Arthur F. Kavanaugh; Stanley B. Cohe 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 279 KB 👁 2 views